Generic Zantac For Infants

You may also know it by its generic name ranitidine.

Generic zantac for infants.

In this article momjunction addresses these questions and more about using zantac for infants. How should it be used. If you are treating your newborn baby with ranitidine zantac for heartburn you are not alone. Zantac is an over the counter otc acid reducer available for the relief and prevention of heartburn associated with acid indigestion and sour stomach.

Health officials said earlier this month they are looking into how the drugs came to be contaminated. Zantac is available in 75 mg or 150 mg tablets as well as zantac 150 cool mint tablets. Ranitidine is a type of histamine 2 h2 blocker and is particularly used to suppress the stomach cells from producing excess acids and thus prevent heartburn. To relieve symptoms swallow 1 tablet with a glass of water.

The following 3 subsections provide dosing information for each of the pediatric indications. Zantac and its generic equivalents are used by millions of people including. Zantac ranitidine is commonly given to babies and people who are pregnant to ease acid reflux and heartburn. The fda asked manufacturers to pull the drug from shelves immediately.

As many as 70 of infants vomit at least once every day in their first four months of life due to ger. Ranitidine blocks acid production in the stomach so is an acid suppressing medication. Ranitidine belongs to a group of drugs called h2 antagonists which mean they act by blocking h2 a chemical that stimulates acid secretion in the stomach which means less stomach acid is produced. The safety and effectiveness of zantac have been established in the age group of 1 month to 16 years.

In fact gastroesophageal reflux ger also called heartburn acid reflux or indigestion is extremely common in infants and children. In the treatment of other indications safety and efficacy have not been established in patients younger than 1 month prescription only formulations and 12 years over the counter formulations. Zantac is one drug that treats excess stomach acid and related conditions. There is insufficient information about the pharmacokinetics of zantac in neonatal patients aged younger than 1 month to make dosing recommendations.

Infants who are given zantac may experience several mild side effects and be at increased risk for bone fractures food allergies and cancer based on recent fda pharmaceutical research. This drug is not recommended for use in children when used to treat pathological hypersecretory conditions or to maintain healing of erosive esophagitis.